Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05027464 · ClinicalTrials.gov registry record · NA
Developing and Testing a COVID-19 Vaccination Acceptance Intervention
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 338,718
- Enrollment target
NCT05027464: Completed NA study, sponsored by VA Office of Research and Development.
NCT05027464 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 338,718 participants, above the 1,398-participant average among 58,714 other NA trials with a reported enrollment target (24129% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05027464, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 338,718 participants
- Enrollment target
Study Summary
The COVID-19 pandemic has resulted in significant loss of life and suffering with total case and death counts increasing daily, particularly with the emergence of the delta variant. COVID-19 vaccines have proven highly effective in preventing severe illness, hospitalization, and death. Nevertheless, according to VA data sources, only 56% of all U.S. Veterans have been vaccinated to date, largely owing to vaccine hesitancy and lack of access to vaccination. Thus, there is a critical need for evidence-based interventions to increase COVID-19 vaccine acceptance and access among Veterans, many of whom are vulnerable to poor outcomes of COVID-19. The overall goal of this study is to increase COVID-19 vaccination in Veterans of VISNs 16 and 21 who remain unvaccinated either because of vaccine hesitancy or lack of access to COVID-19 vaccine. Specifically, the investigators will test a COVID-19 Vaccine Acceptance Intervention (Motivational Interviewing) plus Implementation Facilitation.
Primary Outcome
A greater proportion of Veterans in the intervention group will receive any dose of COVID-19 vaccination compared to usual care.
Interventions
- BEHAVIORAL Moving to COVID-19 Vaccine Acceptance Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338,718 participants |
| Start Date | 2022-04-05 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT05027464 record still lists
NCT05027464 is an interventional study that assigns participants to a tested intervention. Its 338,718 participants enrollment target places it among the larger protocols in the corpus, above the 1,398-participant average among 58,714 other NA trials with a reported enrollment target (24129% higher).
The record links to 0 conditions, and to 1 intervention - of which Moving to COVID-19 Vaccine Acceptance Intervention is the first listed.
NCT05027464 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05027464 about?
NCT05027464 is a clinical study titled "Developing and Testing a COVID-19 Vaccination Acceptance Intervention". The COVID-19 pandemic has resulted in significant loss of life and suffering with total case and death counts increasing daily, particularly with the emergence of the delta variant. COVID-19 vaccines have proven highly effective in preventing severe illness, hospitalization, and death. Nevertheless,...
What is the current status of trial NCT05027464?
This trial is currently completed. It is a NA study. The enrollment target is 338,718 participants. The study started on 2022-04-05. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT05027464?
The interventions under investigation include: Moving to COVID-19 Vaccine Acceptance Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05027464?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05027464's enrollment target sits among peer trials
338,718 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI